Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 70,445 | 239,240 | 666,655 | 88,311 | 84,512 |
| Cost of Goods | 21,496 | 15,325 | 14,115 | 36,669 | 60,619 |
| Gross Profit | 48,949 | 223,915 | 652,540 | 51,642 | 23,893 |
| Operating Expenses | 227,463 | 123,170 | 137,142 | 183,391 | 158,530 |
| Operating Income | -178,018 | 101,070 | 515,513 | -131,080 | -134,018 |
| Interest Expense | 5,482 | 5,518 | 5,723 | 7,585 | 4,236 |
| Other Income | -19,536 | 11,902 | 10,056 | 65,084 | 15,922 |
| Pre-tax Income | -203,036 | 107,454 | 519,846 | -73,581 | -122,332 |
| Income Tax | -657 | 946 | 1,200 | 7,449 | -1,032 |
| Net Income Continuous | -202,379 | 106,508 | 518,646 | -81,030 | -121,300 |
| Net Income | $-202,379 | $106,508 | $518,646 | $-81,030 | $-121,300 |
| EPS Basic Total Ops | -1.25 | 0.66 | 3.22 | -0.51 | -0.76 |
| EPS Basic Continuous Ops | -1.25 | 0.66 | 3.22 | -0.51 | -0.76 |
| EPS Diluted Total Ops | -1.25 | 0.62 | 2.93 | -0.41 | -0.76 |
| EPS Diluted Continuous Ops | -1.25 | 0.60 | 2.92 | -0.40 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -0.62 | 0.62 | 2.93 | -0.51 | -0.76 |
| EBITDA(a) | $-171,433 | $108,633 | $523,853 | $-118,563 | $-121,318 |